McCain urges Trump to make good on promise to address high drug prices

McCain urges Trump to make good on promise to address high drug prices
© Greg Nash

Sens. John McCainJohn Sidney McCainMcConnell: GOP could try to repeal ObamaCare again after midterms Comey donates maximum amount to Democratic challenger in Virginia House race Live coverage: McSally clashes with Sinema in Arizona Senate debate MORE (R-Ariz.) and Tammy BaldwinTammy Suzanne BaldwinTreasury sets politics aside, admits China isn't a currency manipulator Hillicon Valley: Facebook deletes accounts for political 'spam' | Leaked research shows Google's struggles with online free speech | Trump's praise for North Korea complicates cyber deterrence | Senators want Google memo on privacy bug Poll: Baldwin leads GOP challenger by double digits in Wisconsin MORE (D-Wis.) on Monday called on President TrumpDonald John TrumpThe Guardian slams Trump over comments about assault on reporter Five takeaways from the first North Dakota Senate debate Watchdog org: Tillerson used million in taxpayer funds to fly throughout US MORE to make good on his promise to lower drug prices, writing that the problem "is only getting worse." 

The Trump administration has yet to take substantive action toward reducing the cost of prescription drugs despite promising to do so several times last year and in his State of the Union address last month. 

"We write to urge you to make good on your promise and make fixing the problem of high drug prices a top priority for you and your administration," the senators wrote in a letter to Trump. 


McCain and Baldwin urged the administration to back their bill, which would require drug manufacturers to justify their pricing and provide a breakdown of expenses before increasing the costs of some medicines. 

"This will provide taxpayers, consumers and policymakers with more information, including research and development, marketing and advertising costs," the senators wrote. 

"Drug companies are making lifesaving treatments unaffordable and are forcing families, seniors, taxpayers and our health care system to continue to foot the bill for these price increases with no systematic transparency. It is clear that the market is broken."

The senators wrote that transparency is a "critical first step" in addressing high drug prices. 

"You promised to take on high drug prices as your top priority, so we urge you to call on leadership in Congress to take up and pass our bipartisan legislation," they wrote.